Marizyme, Inc. (MRZM) financial statements (2023 and earlier)

Company profile

Business Address 555 HERITAGE DRIVE
JUPITER, FL 33458
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
3/31/2018
12/31/2017
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,0722,9030029521,155
Cash and cash equivalents4,0722,9030029521,155
Receivables941    4,143
Inventory, net of allowances, customer advances and progress billings2256    
Inventory2256     
Prepaid expense257106 2017 
Assets held-for-sale, not part of disposal group    120131
Prepaid expense and other current assets84
Assets held-for-sale385
Income taxes receivable177
Other undisclosed current assets41   627500
Total current assets:4,4023,1060201712096,444
Noncurrent Assets
Operating lease, right-of-use asset1,1591,318 
Property, plant and equipment137    333
Long-term investments and receivables      856
Long-term investments      428
Accounts and financing receivable, after allowance for credit loss      428
Intangible assets, net (including goodwill)60,05742,27828,61328,600  46,462
Goodwill7,191     34,255
Intangible assets, net (excluding goodwill)52,86642,27828,61328,600  12,207
Prepaid expense and other noncurrent assets156
Assets held-for-sale, long lived1,847
Other undisclosed noncurrent assets369374  2,6102,610704
Total noncurrent assets:61,59843,97728,61328,6002,6102,61050,358
TOTAL ASSETS:65,99947,08428,61328,6202,7822,81956,802
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,5964782704335 6,242
Accounts payable    35  
Other undisclosed accounts payable and accrued liabilities1,59647827043  6,242
Debt128     1,290
Due to related parties1,133     3,152
Deferred revenue and credits  6,100
Other liabilities      860
Other undisclosed current liabilities277243  628653584
Total current liabilities:3,1347212704366365318,227
Noncurrent Liabilities
Long-term debt and lease obligation1,3771,075    3,716
Long-term debt, excluding current maturities495     3,716
Operating lease, liability8821,075 
Liabilities, other than long-term debt2,485     166
Pension and other postretirement defined benefit plans, liabilities166
Derivative instruments and hedges, liabilities2,485      
Other undisclosed noncurrent liabilities11,313(1,075)    160
Total noncurrent liabilities:15,1751,075    4,042
Total liabilities:18,3091,7962704366365322,269
Stockholders' equity
Stockholders' equity attributable to parent, including:47,69045,28828,34328,5772,1192,16731,189
Common stock41362020323229
Treasury stock, value  (16)(16)(16)(16) 
Additional paid in capital95,47382,07759,27858,45529,76329,7633
Accumulated other comprehensive income (loss)    (48)(571)443
Accumulated deficit(47,824)(36,826)(30,981)(29,923)(27,653)(27,083)(18,975)
Other additional capital  41414141 
Other undisclosed stockholders' equity attributable to parent    0 49,689
Stockholders' equity attributable to noncontrolling interest      3,345
Total stockholders' equity:47,69045,28828,34328,5772,1192,16734,533
TOTAL LIABILITIES AND EQUITY:65,99947,08428,61328,6202,7822,81956,802

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
3/31/2018
12/31/2017
12/31/2012
Revenues210197 20 10125,736
Revenue, net  25,736
Other income     68
Cost of revenue   (20)  (14,615)
Cost of goods and services sold      (14,615)
Other undisclosed gross profit     (87) 
Gross profit:210197 0 1411,121
Operating expenses(9,032)(5,997)(1,058)(247) (139)(19,565)
Other operating income (expense), net     (446)1,532
Other expenses     (514) 
Other undisclosed operating income (loss)     446(1,532)
Operating loss:(8,821)(5,800)(1,058)(247) (125)(8,445)
Nonoperating expense(2,177)(45) (2)  (1,532)
Other nonoperating expense   (2)  (1,055)
Interest and debt expense(664)(45)(30)   (480)
Other undisclosed income from continuing operations before equity method investments, income taxes      480
Loss from continuing operations before equity method investments, income taxes:(11,661)(5,891)(1,088)(249) (125)(9,977)
Loss from equity method investments      (228)
Loss from continuing operations before income taxes:(11,661)(5,891)(1,088)(249) (125)(10,204)
Income tax expense      (1,432)
Loss before gain (loss) on sale of properties:(11,661)(5,891)(1,088)(249) (125)(11,637)
Other undisclosed net income6644530   268
Net loss:(10,998)(5,845)(1,058)(249) (125)(11,368)
Other undisclosed net income (loss) attributable to parent     (446)4,541
Net loss available to common stockholders, diluted:(10,998)(5,845)(1,058)(249) (571)(6,827)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
3/31/2018
12/31/2017
12/31/2012
Net loss:(10,998)(5,845)(1,058)(249) (125)(11,368)
Other undisclosed comprehensive loss      (103)
Comprehensive loss:(10,998)(5,845)(1,058)(249) (125)(11,471)
Comprehensive loss, net of tax, attributable to noncontrolling interest      (51)
Other undisclosed comprehensive income, net of tax, attributable to parent      4,644
Comprehensive loss, net of tax, attributable to parent:(10,998)(5,845)(1,058)(249) (125)(6,878)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: